← FDA Drug Approvals (Drugs@FDA)
CHLOROTHIAZIDE W/ RESERPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS
Drug application
- FDA Application #
ANDA088151- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CHLOROTHIAZIDE W/ RESERPINE
- Generic name
- Chlorothiazide
- Active ingredients
- CHLOROTHIAZIDE; RESERPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WATSON LABS
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown